PCOS: Clinical Trials

6 trials for PCOS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 6
Phase 23Completed 3

Follow PCOS: new trials by email Literature Review of PCOS trials Research Report on PCOS

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25
Cramp Bites by Aunt Flo's Kitchen - Dysmenorrhea Primary, Dysmenorrhea
Phase 2 / Phase 3CompletedCornell University122022-07-212024-04-12
Treating PCOS With Semaglutide vs Active Lifestyle Intervention
Semaglutide 3mg and 7mg [Rybelsus], Weight loss diet - PCOS, Adolescent Obesity
Phase 2 / Phase 3CompletedUniversity of Colorado, Denver602019-05-032025-11-25
Comparing the Effects of Oral Contraceptive Pills Versus Metformin
OCP + Metformin, OCP + Placebo, Metformin + Placebo - PCOS
Phase 3CompletedAnuja Dokras2402018-01-152025-11-05
Metabolic and Neuro-Endocrine Effect of Treating PCOS in Adolescents
Metformin and Spironolactone - PCOS
Phase 2 / Phase 3CompletedChildren's Mercy Hospital Kansas City122016-07-022021-02-23
Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS)
degarelix (long acting GnRH antagonist), cetrorelix 0.25mg - PCOS, OHSS
Phase 3CompletedCentre for Endocrinology and Reproductive Medicine, Italy802012-11-012016-04-27
Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)
Dexamethasone, recombinant human chorionic gonadotropin (r-hCG) - PCOS
Phase 3CompletedUniversity of California, San Diego242011-08-012019-04-30

Narrower conditions

Menstruation Disturbances (2)  ·  Dysmenorrhea (1)  ·  Infertility (1)  ·  Insulin Resistance (1)  ·  Muscle Cramp (1)  ·  Non-alcoholic Fatty Liver Disease (1)  ·  Oligomenorrhea (1)  ·  Ovarian Cysts (1)  ·  Pediatric Obesity (1)  ·  Polycystic Ovary Syndrome (1)  ·  Premenstrual Dysphoric Disorder (1)  ·  Premenstrual Syndrome (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (3)  ·  Genital Diseases (2)  ·  Pathologic Processes (2)  ·  Signs and Symptoms (2)  ·  Urogenital Diseases (2)  ·  Adnexal Diseases (1)  ·  Body Weight (1)  ·  Cysts (1)  ·  Depressive Disorder (1)  ·  Digestive System Diseases (1)  ·  Endocrine System Diseases (1)  ·  Fatty Liver (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases, Female (1)

Interventions

Metformin (2)  ·  Chorionic Gonadotropin (1)  ·  Dexamethasone (1)  ·  Diet, Reducing (1)  ·  Ovidrel (1)  ·  Spironolactone (1)  ·  acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide (1)  ·  cetrorelix (1)  ·  semaglutide (1)

Sponsors

Anuja Dokras (1)  ·  Centre for Endocrinology and Reproductive Medicine, Italy (1)  ·  Children's Mercy Hospital Kansas City (1)  ·  Cornell University (1)  ·  University of California, San Diego (1)  ·  University of Colorado, Denver (1)

Countries

United States (5)  ·  Italy (1)

Top investigators

Anuja Dokras, MD (1)  ·  Marco Sbracia, MD (1)  ·  Melanie Cree-Green, MD, PhD (1)  ·  R. Jeffery Chang, M.D. (1)  ·  Tania Burgert, MD (1)

Results publications

PMID 22197127, PMID 41359669, PMID 42014131

NIH funding

R01DK120612 (1), R01HD091350 (1)